Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PTGES | O14684 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | GLA | P06280 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LIPE | Q05469 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15731331 | 0.82 | SCN9A (0.47) | MRGPRX4SMN1; SMN2KDM4EPOLBGAA | |
| SCHEMBL5200375 | 0.82 | GLA (0.53) | SMN1; SMN2KDM4EPOLBGAALMNA | |
| SCHEMBL19976665 | 0.80 | GLA (0.52) | SMN1; SMN2KDM4EPOLBGAALMNA | |
| Fluopyram SCHEMBL29353266 | 0.80 | GLA (0.59) | SMN1; SMN2KDM4EPOLBGAAMEN1 | |
| SCHEMBL15703037 | 0.80 | NPC1 (0.47) | SMN1; SMN2KDM4EPOLBGAASCN9A | |
| Fluopyram SCHEMBL67230 | 0.80 | GLA (0.59) | SMN1; SMN2KDM4EPOLBGAAMEN1 | |
| SCHEMBL20363543 | 0.80 | LMNA (0.49) | SMN1; SMN2KDM4ESCN9ALMNAMEN1 | |
| SCHEMBL3781264 | 0.78 | GLA (0.54) | SMN1; SMN2KDM4EPOLBGAAMEN1 | |
| SCHEMBL14921068 | 0.78 | P2RX7 (0.47) | SMN1; SMN2KDM4EPOLBGAALMNA | |
| SCHEMBL4425267 | 0.78 | KMT2A (0.47) | SMN1; SMN2KDM4EPOLBGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090298890-A1 | NEW N-METHYL BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2009-12-03 | — | — | US | disclosed |
| EP-2049489-A2 | N-METHYL BENZAMIDE DERIVATIVES USEFUL AS FUNGICIDES | Bayer CropScience SA (FR) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008003744-A2 | N-METHYL BENZAMIDE DERIVATIVES USEFUL AS FUNGICIDES | BAYER CROPSCIENCE SA (FR) | 2008-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090298890-A1 | NEW N-METHYL BENZAMIDE DERIVATIVES | CYP51A1, GANAB, ERG28 | MRGPRX4 1156/4885SMN1; SMN2 2040/4885KDM4E 411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.